Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

Source:http://linkedlifedata.com/resource/pubmed/id/8548765

Cancer Res. 1996 Jan 1 56 1 21-6

Download in:

View as

General Info

PMID
8548765